Authors: Toso, Christian; Pawlick, Rena; Lacotte, Stéphanie; Edgar, Ryan; Davis, Joy; McCall, Michael; Morel, Philippe; Mentha, Gilles; Berney, Thierry; Shapiro, A. M. James

Source: Cell Transplantation, Volume 20, Number 6, 2011 , pp. 955-962(8)

Publisher: Cognizant Communication Corporation

Abstract:

Improved posttransplant monitoring and on-time detection of rejection could improve islet transplantation outcome. The present study explored the possibility of detecting harmful events after mouse islet transplantation measuring the immune responsiveness against islet extracts. Mouse islet transplantations were performed using various donor/recipient combinations, exploring autoimmune (NOD/SCID to NOD, n = 6) and alloimmune events (C57BL/6 to BALB/c, n = 20), a combination of both (C57BL/6 to NOD, n = 8), the absence of both (BALB/c to BALB/c, n = 21), or naive, nontransplanted control mice (n = 14). The immune reactivity was measured by ELISPOT, looking at the ex vivo release of IFN-γ from splenocytes stimulated by islet donor extracts (sonicated islets). The immune reactivity was not altered in the syngeneic and autoimmune models, demonstrating similar levels as nontransplanted controls (p = 0.46 and p = 0.6). Conversely, the occurrence of an allogeneic rejection alone or in combination to autoimmunity was associated to an increase in the level of immune reactivity (p = 0.023 and p = 0.003 vs. respective controls). The observed increase was transient and lost in the postrejection period or after treatment with CTLA4-Ig. Overall, allogeneic rejection was associated to a transient increase in the reactivity of splenocytes against islet proteins. Such a strategy has the potential to improve islet graft monitoring in human and should be further explored.

Articles that cite this article?

Keywords: Monitoring; Diabetes; Islets; Transplantation; Cytokine

Document Type: Research article

DOI: http://dx.doi.org/10.3727/096368910X539137

Affiliations: 1: Transplant Unit, Department of Surgery, University of Geneva Hospitals, Geneva, Switzerland

Publication date: 2011-06-01

More about this publication?

• Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
  

Related content

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Biology ,  Biotechnology ,  Pharmacology ,  Surgery
• By this author: Toso, Christian ;  Pawlick, Rena ;  Lacotte, Stéphanie ;  Edgar, Ryan ;  Davis, Joy ;  McCall, Michael ;  Morel, Philippe ;  Mentha, Gilles ;  Berney, Thierry ;  Shapiro, A. M. James

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers